Hodgkin's lymphoma. II: Treatment and delayed morbidity.
- 18 July 1992
- Vol. 305 (6846) , 173-176
- https://doi.org/10.1136/bmj.305.6846.173
Abstract
No abstract availableThis publication has 43 references indexed in Scilit:
- Suppression of Thromboxane A2but Not of Systemic Prostacyclin by Controlled-Release AspirinNew England Journal of Medicine, 1991
- Pericarditis and myocardial infarctions after Hodgkin's disease therapyInternational Journal of Radiation Oncology*Biology*Physics, 1991
- Recombinant Granulocyte-Macrophage Colony-Stimulating Factor after Autologous Bone Marrow Transplantation for Lymphoid CancerNew England Journal of Medicine, 1991
- Prognostic factors in Hodgkin's diseaseCancer Treatment Reviews, 1991
- The management of early Hodgkin's diseaseBlood Reviews, 1990
- Randomized Trial of Chemotherapy Versus Chemotherapy Plus Radiotherapy for Stage I-II Hodgkin's DiseaseJNCI Journal of the National Cancer Institute, 1988
- Initial chemotherapy and low-dose radiation in limited fields in childhood Hodgkin's disease: results of a joint cooperative study by the French society of pediatric oncology (SFOP) and hôpital Saint-Louis, ParisInternational Journal of Radiation Oncology*Biology*Physics, 1988
- Risk of Second Cancers after Treatment for Hodgkin's DiseaseNew England Journal of Medicine, 1988
- REVIEW OF BRITISH NATIONAL LYMPHOMA INVESTIGATION STUDIES OF HODGKIN'S DISEASE AND DEVELOPMENT OF PROGNOSTIC INDEXThe Lancet, 1985
- The evolution and summary results of the Stanford randomized clinical trials of the management of Hodgkin's disease: 1962–1984International Journal of Radiation Oncology*Biology*Physics, 1985